Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxegol for Prevention of Lower GI Paralysis in ICU
NCT02977286Phase 4Terminated
- Sponsor
- Tufts Medical Center
- Start
- Jan 2017
- Primary completion
- Oct 2019
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of naloxegol in paralytic ileus, opioid-induced constipation (OIC), sponsored by Tufts Medical Center. Started Jan 2017; status: terminated.
02
Drugs
naloxegol
03
Conditions
paralytic ileusopioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT02977286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02977286.